A review of randomized trials comparing coronary angioplasty and bypass grafting

Current Opinion in Cardiology

Volumn 11, Issue 6, 1996, Pages 583-590

  Anderson, William D ^a   King III, Spencer B ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; REOPERATION; REVIEW; TREATMENT OUTCOME;

EID: 0029802822     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199611000-00005     Document Type: Review

References (32)

1. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R, et al.: Effect of coronary artery bypass surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Surgery Trialists Collaboration. Lancet 1994, 344:563-570.
2. Detre K, Yah W, Kelsey S, Williams D, Desvigne-Nickens P, Holmes D, Bourassa M, King S III, Faxon D, Kent K: Has Improvement in PTCA Intervention affected long-term prognosis? (The NHLBI Registry experience). Circulation 1995, 91:2868-2875. This report is the National Heart, Lung, and Blood Institute's registry experience from two time periods, 1977 to 1981 and 1985 to 1986. Improvements in morbid event rates, a reduced need for CABG, and similar mortality rates were seen when the 1985 to 1986 participants were compared with their counter-parts in the earlier registry.
3. The Bypass Angioplasty Revascularization Investigation Investigators: Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996, 335:217-225. The largest of the randomized trials comparing PTCA and CABG, BARI demonstrated similar mortality rates and MI-free survival in the two groups after 5 years of follow-up, except perhaps in patients with diabetes requiring medical therapy. More repeat revascularization procedures were required in the angioplasty cohort.
4. CABRI Trial Participants: First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation). Lancet 1995, 346:1179-1184. A multicenter, European trial, CABRI demonstrated similar overall mortality rates for patients treated with PTCA or CABG. Recurrent angina and repeat revascularization procedures were significantly associated with random assignment to angioplasty.
5. RITA Trial Participants: Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) Trial. Lancet 1993, 341:573-580.
6. King SB III, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH, Alazraki NP, Guyton RA, Zhao XQ: A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994, 331:1044-1050.
7. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J Bleifeld W: A randomized study of coronary angioplasty with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 1994, 331:1037-1043.
8. Hueb WA, Bellotti G, de Oliveira SA, Arie S, de Albuquerque CP, Jatene AD, Pileggi F: The Medicine Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 1995, 26:1600-1605.
9. Goy JJ, Eeckhout E, Burnand B, Vogt P, Stauffer JC, Hurni M, Stumpe F, Ruchat P, Sadeghi H, Kappanberger L: Coronary angioplasty versus left internal mammary artery grafting for isolated left anterior descending stenosis. Lancet 1994, 343:1449-1453.
10. Rodriguez A, Boullon F, Perez-Balino N, Paviotti C, Liprandi MIS, Palacios IF: Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI): in-hospital results and 1-year follow-up. J Am Coll Cardiol 1993, 22:1060-1067.
11. Puel J, Karouny E, Marco F, Assoun B, Galinier M, Elbaz M, Alibelli MJ, Bounhoure JP: Angioplasty versus surgery in multivessel disease: immediate results and in-hospital outcome in a randomized prospective study [abstract]. Circulation 1992, 86:1-372.
12. Favaloro RG: Saphenous vein autograft replacement of severe segmental coronary artery occlusions: operative technique. Ann Thorac Surg 1968, 5:334-339.
13. CASS Principal Investigators and their Associates: Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation 1983, 68:939-950.
14. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group: Eleven-year survival in the Veterans Administration randomized trial of coronary artery bypass surgery for stable angina. N Engl J Med 1984, 311:1333-1339.
15. Varnauskas E, European Coronary Surgery Study Group: Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 1988, 319:332-337.
16. Califf RM, Harrell FE Jr, Lee KL, Hlatky MA, Mark DB, Rankin JS, Jones RH, Muhlbaier LH, Oldham HN, Pryor DB: The evolution of medical and surgical therapy for coronary disease: a 15 year perspective [abstract]. Circulation 1987, 76(suppl IV):IV-350.
17. CASS Principal Investigators and their Associates: Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups. Circulation 1983, 68:951-960.
18. Gruentzig AR: Transluminal dilatation of coronary artery stenosis [letter]. Lancet 1978, 11:263.
19. King SB III, Schlumpf M: Ten-year completed follow-up of percutaneous transluminal coronary angioplasty: the early Zurich experience. J Am Coll Cardiol 1993, 22:353-360.
20. Kent KM, Mullin SM, Passamani ER, eds: Proceedings of the National Heart, Lung, and Blood Institute Workshop on the Outcome of Percutaneous Transluminal Angioplasty (June 7-8, 1983). Am J Cardiol 1984, 53:1C.
21. Parisi AF, Folland ED, Hartigan P for the Veterans Affairs Angioplasty Compared to Medicine Investigators: A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992, 326:10-16.
22. Weintraub WS, King SB III, Jones EL, Douglas JS, Craver JM, Liberman HA, Morris DC, Guyton RA: Coronary surgery and coronary angioplasty in patients with two-vessel coronary artery disease. Am J Cardiol 1993, 71:511-517.
23. Vacek JL, Rosamond TL, Stites HE, Rowe SK, Robuck W, Dittmeier G, Beauchamp GD: Comparison of percutaneous transluminal coronary angioplasty versus coronary artery bypass grafting for multivessel coronary artery disease. Am J Cardiol 1992, 69:592-597.
24. Mark DB, Nelson CL, Califf RM, Harrell FE, Lee KL, Jones RH, et al.: Continuing evolution of therapy for coronary artery disease: initial results from the era of coronary angioplasty. Circulation 1994, 89:2015-2025.
25. Gersh BJ: The management of patients with stable angina and multivessel disease (PTCA or coronary bypass surgery?). Eur Heart J 1995, 16(suppl E):32-35.
26. Breeman A, Boersma E, Deckers JW, Serruys PW, on behalf of the CABRI Investigators: The impact of completeness of revascularisation on adverse cardiac events at 1 year follow-up in 1021 CABRI patients. J Am Coll Cardiol 1995, 25:55A.
27. Kosinski AS, Barnhart HX, Weintraub WS, Guyton RA, King SB III: Five year outcome after coronary surgery or coronary surgery: results from the Emory Angioplasty vs Surgery Trial (EAST) [abstract]. Circulation 1995, 91(suppl 1):1-543.
28. Weintraub WS, Maulden PD, Becker E, Kosinski AS, King SB III: A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Circulation 1995, 92:2831-2840. A comparison of the hospital costs and physician charges for patients in EAST. Although initial costs were far lower in patients who underwent angioplasty, these cost savings were significantly reduced after 3 years of follow-up due to repeat revascularization procedures.
29. Hamm CW, Kalmar P, Reimers J, Rupprecht HJ, Schmidt C, Ischinger T: Clinical outcome and costs of CABG and PTCA in the GABI Study over 2 years follow-up. J Am Coll Cardiol 1995, 25:55A.
30. Rodriguez A, Mele E, Peyregne E, Bullon F, Perez-Balino N, Liprandi MIS, Palacios IF: Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI). J Am Coll Cardiol 1996, 27:1178-1184. This report outlines 3-year follow-up of patients in the ERACI trial. Survival with freedom from MI, angina, and repeat revascularization procedures was significantly better in the CABG group, albeit at a higher cost.
31. Pocock SJ, Henderson RA, Rickards AF, Hampton JR, King SB III, Hamm CW, Puel J, Hueb W, Goy JJ, Rodrigues A: Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995, 346:1184-1189. Comprehensive meta-analysis of randomized trials comparing the relative efficacies of PTCA and CABG in patients with both single- and multivessel disease.
32. Sim I, Gupta M, McDonald K, Bourassa MG, Hlatky MA: Meta-analysis of randomized trials comparing coronary artery bypass surgery with percutaneous transluminal coronary angioplasty in multivessel coronary artery disease. Am J Cardiol 1995, 76:1025-1029. Meta-analysis of randomized trials comparing the relative efficacies of PTCA and CABG in patients with multivessel disease only.